These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14444340)

  • 1. Management of severe bone pain in generalized neoplastic disease with combined anabolic steroids (deladumone).
    SEAMAN AJ
    Curr Ther Res Clin Exp; 1959 Oct; 1():64-8. PubMed ID: 14444340
    [No Abstract]   [Full Text] [Related]  

  • 2. Experience with anabolic steroid (deladumone) therapy for decubitus ulcers: a preliminary report.
    FORSTER W; HENDERSON AL
    Curr Ther Res Clin Exp; 1959 Nov; 1():97-101. PubMed ID: 13824044
    [No Abstract]   [Full Text] [Related]  

  • 3. The usefulness of balanced anabolic steroid (deladumone) therapy in osteoporosis resulting from bone therapy.
    HANNA CB; HASTINGS WD
    Curr Ther Res Clin Exp; 1959 Dec; 1():130-4. PubMed ID: 14399526
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of Deladumone. The control of postpartum breast engorgement lactation and pain.
    BISCA BV; TETERIS NJ; YANNONE ME
    Ohio State Med J; 1962 Mar; 58():303-5. PubMed ID: 13869460
    [No Abstract]   [Full Text] [Related]  

  • 5. Deladumone for breast comfort.
    HERSCHELMANN RF; PARTRIDGE AC
    Am J Nurs; 1959 Sep; 59():1252-4. PubMed ID: 14401394
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of anabolic steroid (deladumone) therapy on the clinical and metabolic aspects of Paget's disease.
    MCGAVACK TH; SEEGERS W; REIFENSTEIN EC
    J Am Geriatr Soc; 1961 Jul; 9():533-67. PubMed ID: 13773925
    [No Abstract]   [Full Text] [Related]  

  • 7. [Modification of myocardial metabolism by anabolic substances, their evaluation in the rehabilitation therapy of chronic myocardial lesions].
    FIEGEL G
    Med Klin; 1962 Mar; 57():519-23. PubMed ID: 13892744
    [No Abstract]   [Full Text] [Related]  

  • 8. [Alteration of myocardial metabolism by anabolic substances, their evaluation in rehabilitation treatment of chronic myocardial lesions].
    FIEGEL G
    Med Klin; 1962 Mar; 57():519-23. PubMed ID: 13892743
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hormone therapy of severe climacteric endocrine deficiencies].
    WARNECKE G
    Med Klin; 1960 Jan; 55():192-3. PubMed ID: 13842911
    [No Abstract]   [Full Text] [Related]  

  • 10. [CLINICAL AND EXPERIMENTAL POINTS OF VIEW ON THE TREATMENT OF TUMOR PATIENTS WITH ANABOLIC STEROIDS].
    DREWS J; FOELSCH E
    Med Klin; 1964 Oct; 59():1585-7. PubMed ID: 14334921
    [No Abstract]   [Full Text] [Related]  

  • 11. [EFFECT OF SOME ANABOLIC AND ANTIANABOLIC PREPARATIONS ON THE MINERAL CONSTITUENTS OF BONE TISSUE].
    TESAREK B; PROKOPOVA ROUBALOVA D
    Fysiatr Vestn Cesk Fysiatr Spol; 1965 Mar; 43():108-14. PubMed ID: 14276048
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic study of a new anabolic drug: nor-androstenolone phenylpropionate].
    ZARA M; LUMBROSO A
    Sem Hop Ther Paris; 1960 May; 36():454-7. PubMed ID: 13847031
    [No Abstract]   [Full Text] [Related]  

  • 13. [Suppression of lacation by injection of testosterone enanthate and of estradiol valerianate during labor or immediately after delivery. (Apropos of 579 cases)].
    VAN DEN HAUTE C
    Bull Soc R Belge Gynecol Obstet; 1962; 32():291-306. PubMed ID: 13924536
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metabolism balance studies and hormone therapy in various forms of osteoporosis].
    KUHLENCORDT F; RAUSCH-STROOMANN JG
    Verh Dtsch Ges Inn Med; 1959; 65():162-6. PubMed ID: 14412558
    [No Abstract]   [Full Text] [Related]  

  • 15. [Androgen-estrogen therapy in osteoporosis].
    WEBER HJ
    Munch Med Wochenschr; 1960 Oct; 102():1989-91. PubMed ID: 13783623
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with a new, orally effective hormone preparation in the therapy of climacteric disorders].
    ZOELFFEL R
    Med Welt; 1960 Mar; 13():685-7. PubMed ID: 13847699
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of hormone dosage and time of administration on suppression of lactation.
    FOLEY WE
    Am J Obstet Gynecol; 1961 Oct; 82():856-9. PubMed ID: 13893836
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of lactation. Advantages of immediate parenteral administration of androgen-estrogen.
    RODENBERG TA; SIMON HJ
    Obstet Gynecol; 1960 Apr; 15():522-5. PubMed ID: 14438143
    [No Abstract]   [Full Text] [Related]  

  • 19. [The protein-anabolic properties of 4-hydroxy-17alpha-methyltestosterone in some forms of osseous atrophy].
    QUAINI L; VALOBRA M
    Minerva Ortop; 1961 Oct; 12():711-7. PubMed ID: 14489378
    [No Abstract]   [Full Text] [Related]  

  • 20. An evaluation of a combination of testosterone enanthate with estradiol valerate (deladumone) for the inhibition of lactation.
    STEIN WW
    Am J Obstet Gynecol; 1958 Jul; 76(1):108-17. PubMed ID: 13545286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.